Fecal Microbiota Transplantation
56
12
15
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
2 terminated out of 56 trials
87.5%
+1.0% vs benchmark
2%
1 trials in Phase 3/4
7%
1 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (56)
Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer
Evaluation of the Outcome of Fecal Microbiota Transplantation
The Efficacy and Safty of FMT in Patients With CID
The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation
Fecal Microbiota Transplant National Registry
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
Microbial Restoration in Inflammatory Bowel Diseases
Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment
Fecal Microbial Transplantation for Rheumatoid Arthritis Trial
Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults
Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
Fecal Microbiota Transplantation in the Treatment of Major LARS
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis